Business   

Sun Pharma arm receives warning letter

MUMBAI: Caraco Pharmaceuticals, a subsidiary of Sun Pharma, on Tuesday said it had received a warning letter from the USFDA over the company’s manufacturing facility in Detroit.

Inadequate and untimely investigation by the quality control unit of certain incidents are contrary to the company’s standard operating procedures, the USFDA said in its letter dated October 31.

The USFDA inspection was held in May 2008. Sun Pharma holds 76 per cent in Caraco Pharmaceuticals and it is listed in the New York Stock Exchange.

Caraco said it would respond to the USFDA within 15 days. — PTI

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

PM heads group on global crisis
Nokia unveils new handsets
Pavers to expand operations in India
U.S. investors watching land acquisition issues closely
Rupee jumps 91 paise against $
Fujitsu to buy Siemens stake in PC venture
Joint venture for solar power equipment
Sun Pharma arm receives warning letter
NDS to invest $150 m in India
Finance Secretary to meet private bankers
Chinese firms keen to set up joint ventures in West Bengal
Delta’s non-stop flight to Atlanta from Mumbai
Exchange Rates
Bullion Rates
Apollo to manage tertiary care in Seychelles
IBM to invest $2 b over three years
Wipro arm sets up shared services centre in Brazil
Fitch rating for Rs. 600-crore TNEB bond
Bosch PAT up 16 % in September quarter
International aluminium conference in Pune
SonicWall sets up support centre in India
Indian Bank assigned BBB- rating by S&P

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu